New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK

By Hayes Daniel   Ethier Stephen   Lippman Marc  

Breast Cancer Research and Treatment, Vol. 100, Iss. 2, 2006-11 ,pp. : 237-238

Springer Publishing Company

Access to resources Recommend Favorite

Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma

By Wu Guang-Li   Yuan Jian-Lin   Huang Xu-Dong   Rong Jun-Fang   Zhang Li-Xia   Liu Yue-Ping   Wang Fu-Li  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3431-3435

Springer Publishing Company

Access to resources Recommend Favorite

Keeping Data Continuous when Analyzing the Prognostic Impact of a Tumor Marker: An Example with Cathepsin D in Breast Cancer

By Bossard N.   Descotes F.   Bremond A.G.   Bobin Y.   De Saint Hilaire P.   Golfier F.   Awada A.   Mathevet P.M.   Berrerd L.   Barbier Y.   Estève J.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 1, 2003-11 ,pp. : 47-59

Springer Publishing Company

Access to resources Recommend Favorite

CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma

By Kayal Smita   Mathur Sandeep   Karak Asis K.   Kumar Lalit   Sharma Atul   Bakhshi Sameer   Raina Vinod  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1031-1037

Informa Healthcare

Access to resources Recommend Favorite

Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck?

By Jatana Kris R   Lang Jas C   Chalmers Jeffrey J  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 481-484

Future Medicine

Access to resources Recommend Favorite